在乳腺癌手术后,血清液中发现Th2/Th17细胞相关的细胞因子
Nicole Pochert1,2, Mariella Schneider1, Melitta B Köpke1
1Department of Obstetrics and Gynecology, University Hospital Augsburg, Augsburg, Germany.
Archives of gynecology and obstetrics
|May 27, 2023
概括
乳腺癌手术后的血清液显示细胞因子增加,特别是IL-6,表明局部免疫反应. 这与在T辅助细胞中观察到的全身免疫变化形成鲜明对比.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 手术并发症 手术并发症
背景情况:
- 血清瘤形成是乳腺癌手术 (乳房切除和股剖析) 后的常见并发症.
- 以前的研究表明,乳房切除术后血清液和血液中的T辅助细胞和Th2/Th17免疫反应增加.
研究的目的:
- 分析乳腺癌患者血清液中的Th2/Th17细胞关联细胞因子含量,包括IL-6.
- 为了进一步研究乳腺切除术后血清体的免疫微环境.
主要方法:
- 在34个血清液样本上进行了多重细胞因子测量 (IL-4,IL-5,IL-13,IL-10,IL-17,IL-22).
- 血清液 (Sf) 中的细胞因子水平与患者血清 (Sp) 和健康对照血清 (Sc) 相比较.
主要成果:
- 与患者血清和健康对照人群相比,血清液在分析的细胞因子中显著富含.
- 干白素-6 (IL-6) 在血清液中显著升高,促进了Th17和Th2的分化,同时抑制了Th1的发展.
结论:
- 血清液中的细胞因子测量表明一个明显的局部免疫事件.
- 血清液中的这种局部免疫反应与之前观察到的T-辅助细胞群体的系统性免疫变化形成鲜明对比.
相关概念视频
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
5.2K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
5.2K
Tumor Immunotherapy
577
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
577


